Interleukin‐1β Disruption Protects Male Mice From Heart Failure With Preserved Ejection Fraction Pathogenesis
Background Heart failure with preserved ejection fraction (HFpEF) is a significant unmet need in cardiovascular medicine and remains an untreatable cardiovascular disease. The role and mechanism of interleukin‐1β in HFpEF pathogenesis are poorly understood. Methods and Results C57/Bl6J and interleuk...
Main Authors: | Balaji K. Srinivas, Aya Bourdi, Jacob D. O'Regan, Kumar D. Malavalli, Nour‐Eddine Rhaleb, Souad Belmadani, Khalid Matrougui |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.029668 |
Similar Items
-
Inflammation as a therapeutic target in heart failure with preserved ejection fraction
by: Zhen Hui Peh, et al.
Published: (2023-06-01) -
The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
by: Becker Al-Khayatt, et al.
Published: (2024-05-01) -
Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
by: Ahmed Hamam, et al.
Published: (2022-12-01) -
Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
by: Yohei Sotomi, et al.
Published: (2021-06-01) -
Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
by: B. Srinivas, et al.
Published: (2024-03-01)